Matches in SemOpenAlex for { <https://semopenalex.org/work/W3206520009> ?p ?o ?g. }
- W3206520009 endingPage "568" @default.
- W3206520009 startingPage "561" @default.
- W3206520009 abstract "This prospective pharmacodynamic (PD) study assessed the effect of the sodium-glucose co-transporter-2 inhibitor (SGLT2i), dapagliflozin, on platelet reactivity.Patients with stable coronary artery disease (CAD) and type 2 diabetes mellitus (T2DM) (n = 27) who were on maintenance dual antiplatelet therapy (DAPT) of aspirin 81 mg daily, and clopidogrel 75 mg daily were recruited. Platelet function was evaluated with the VerifyNow™ P2Y12 assay (Werfen, Bedford, MA, USA) and assessed prior to initiation of and after 10 days of treatment with dapagliflozin 10 mg once-daily dose regimen. Results were compared with a paired t test.Treatment with dapagliflozin significantly decreased P2Y12 reaction units (PRU) by 20%, (95% confidence interval (CI) 8.5-32.6%, p value 0.002). The mean difference in PRU was 36.70 (95% CI 16.66-56.75). No patients experienced any serious adverse events (SAEs).Significantly diminished platelet reactivity was observed on dapagliflozin as compared to without dapagliflozin. This dedicated pharmacodynamic study could be potentially informative and applicable for Trinidadian stable CAD patients with T2DM on DAPT. Further studies are required to confirm these exploratory findings.EDGE ClinicalTrials.gov number NCT04400760." @default.
- W3206520009 created "2021-10-25" @default.
- W3206520009 creator A5003741736 @default.
- W3206520009 creator A5005341323 @default.
- W3206520009 creator A5021391698 @default.
- W3206520009 creator A5035702099 @default.
- W3206520009 creator A5036350601 @default.
- W3206520009 creator A5037899581 @default.
- W3206520009 creator A5038199459 @default.
- W3206520009 creator A5041073646 @default.
- W3206520009 creator A5045583803 @default.
- W3206520009 creator A5050567024 @default.
- W3206520009 creator A5051094346 @default.
- W3206520009 creator A5061630608 @default.
- W3206520009 creator A5062743035 @default.
- W3206520009 creator A5068162084 @default.
- W3206520009 creator A5068420231 @default.
- W3206520009 creator A5071470015 @default.
- W3206520009 creator A5074308432 @default.
- W3206520009 creator A5077010394 @default.
- W3206520009 creator A5081144602 @default.
- W3206520009 date "2021-10-13" @default.
- W3206520009 modified "2023-10-18" @default.
- W3206520009 title "The Effect of Dapagliflozin on Platelet Function Testing Profiles in Diabetic Patients: The EDGE Pilot Study" @default.
- W3206520009 cites W1990018236 @default.
- W3206520009 cites W2075429176 @default.
- W3206520009 cites W2108112200 @default.
- W3206520009 cites W2553261268 @default.
- W3206520009 cites W2576291926 @default.
- W3206520009 cites W2884466498 @default.
- W3206520009 cites W2904119291 @default.
- W3206520009 cites W2974260792 @default.
- W3206520009 cites W2975677680 @default.
- W3206520009 cites W3047536039 @default.
- W3206520009 cites W3081830235 @default.
- W3206520009 cites W3112392549 @default.
- W3206520009 cites W3123741217 @default.
- W3206520009 cites W4292528167 @default.
- W3206520009 doi "https://doi.org/10.1007/s40119-021-00242-6" @default.
- W3206520009 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8555038" @default.
- W3206520009 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34643895" @default.
- W3206520009 hasPublicationYear "2021" @default.
- W3206520009 type Work @default.
- W3206520009 sameAs 3206520009 @default.
- W3206520009 citedByCount "5" @default.
- W3206520009 countsByYear W32065200092022 @default.
- W3206520009 countsByYear W32065200092023 @default.
- W3206520009 crossrefType "journal-article" @default.
- W3206520009 hasAuthorship W3206520009A5003741736 @default.
- W3206520009 hasAuthorship W3206520009A5005341323 @default.
- W3206520009 hasAuthorship W3206520009A5021391698 @default.
- W3206520009 hasAuthorship W3206520009A5035702099 @default.
- W3206520009 hasAuthorship W3206520009A5036350601 @default.
- W3206520009 hasAuthorship W3206520009A5037899581 @default.
- W3206520009 hasAuthorship W3206520009A5038199459 @default.
- W3206520009 hasAuthorship W3206520009A5041073646 @default.
- W3206520009 hasAuthorship W3206520009A5045583803 @default.
- W3206520009 hasAuthorship W3206520009A5050567024 @default.
- W3206520009 hasAuthorship W3206520009A5051094346 @default.
- W3206520009 hasAuthorship W3206520009A5061630608 @default.
- W3206520009 hasAuthorship W3206520009A5062743035 @default.
- W3206520009 hasAuthorship W3206520009A5068162084 @default.
- W3206520009 hasAuthorship W3206520009A5068420231 @default.
- W3206520009 hasAuthorship W3206520009A5071470015 @default.
- W3206520009 hasAuthorship W3206520009A5074308432 @default.
- W3206520009 hasAuthorship W3206520009A5077010394 @default.
- W3206520009 hasAuthorship W3206520009A5081144602 @default.
- W3206520009 hasBestOaLocation W32065200091 @default.
- W3206520009 hasConcept C111113717 @default.
- W3206520009 hasConcept C112705442 @default.
- W3206520009 hasConcept C126322002 @default.
- W3206520009 hasConcept C134018914 @default.
- W3206520009 hasConcept C2777422806 @default.
- W3206520009 hasConcept C2777628954 @default.
- W3206520009 hasConcept C2777849778 @default.
- W3206520009 hasConcept C2778213512 @default.
- W3206520009 hasConcept C2781413609 @default.
- W3206520009 hasConcept C2910068830 @default.
- W3206520009 hasConcept C44249647 @default.
- W3206520009 hasConcept C49059817 @default.
- W3206520009 hasConcept C555293320 @default.
- W3206520009 hasConcept C71924100 @default.
- W3206520009 hasConcept C89560881 @default.
- W3206520009 hasConcept C90924648 @default.
- W3206520009 hasConceptScore W3206520009C111113717 @default.
- W3206520009 hasConceptScore W3206520009C112705442 @default.
- W3206520009 hasConceptScore W3206520009C126322002 @default.
- W3206520009 hasConceptScore W3206520009C134018914 @default.
- W3206520009 hasConceptScore W3206520009C2777422806 @default.
- W3206520009 hasConceptScore W3206520009C2777628954 @default.
- W3206520009 hasConceptScore W3206520009C2777849778 @default.
- W3206520009 hasConceptScore W3206520009C2778213512 @default.
- W3206520009 hasConceptScore W3206520009C2781413609 @default.
- W3206520009 hasConceptScore W3206520009C2910068830 @default.
- W3206520009 hasConceptScore W3206520009C44249647 @default.
- W3206520009 hasConceptScore W3206520009C49059817 @default.
- W3206520009 hasConceptScore W3206520009C555293320 @default.
- W3206520009 hasConceptScore W3206520009C71924100 @default.